Inotek Pharmaceuticals (United States)

Inotek Pharmaceuticals (United States)

Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Inotek Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

43%


Total
Publications

246


Total Open
Publications

106


Total
Citations

16K


Open Access
Percentage

43%


Total
Publications

246


Total Open
Publications

106


Total
Citations

16K

Wikipedia

Website

download

Breakdown

24% 10% 9% 57%

Publisher Open

24%

Both

10%

Other Platform Open

9%

Closed

57%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

15%OA Journal

OA Journal 15%

13

Hybrid 17%

14

No Guarantees 68%

57

Other Platform Open

Domain 75%

36

Institution 21%

10

Other Internet 10%

5

Public 2%

1

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

Europe PMC
Domain
33
PubMed Central
Domain
31
University of Michigan - Deep Blue
Institution
3
Université de Lausanne - SERVAL
Institution
2
University of Debrecen - University of Debrecen Electronic Archive
Institution
2
Figshare
Public
2
CiteSeer X
Other Internet
2
University of Toronto - TSpace
Institution
1
University Computing Centre - Hrčak Portal of scientific journals of Croatia
Other Internet
1
Universitat Politècnica de València - RiuNet
Institution
1
1 / 2

Data updated 17 June 2024

Share

Share

Share